Here is something most life sciences organizations already know but rarely say out loud: Snowflake did its job. The data lake is full. Batch records, deviation logs, CAPA histories, COA repositories, clinical trial evidence, it is all there, unified, queryable, and beautifully governed. And yet the quality director is still chasing approvals through email threads. The compliance team is still manually cross-referencing batch records against specifications before a release decision. The CAPA cycle is still measured in weeks, not hours.
Data centralization was never the finish line. It was the foundation. The question now is whether that foundation does work or just sits there.
I have had this conversation with life sciences leaders more times than I can count. They point to their Snowflake environment as evidence of AI readiness, clean data, good schemas, Cortex AI enabled. And then they describe their actual GxP workflows: batch release, deviation management, CAPA reviews, HCP engagement, CSR evidence consolidation. Every one of them still depends on someone opening a dashboard, interpreting what it says, routing the output to the right approver, and waiting. The intelligence stops at the report. The action still happens somewhere else, by someone else, on a different system.
This is the passive data problem. Information is available. Decisions are still slow. The gap between the two is not a data problem, it is an orchestration and governance problem.
Traditional tools give you visibility. What regulated life sciences operations actually need is execution: agents that can reason across your data, perform GxP workflows with full traceability, and escalate to human reviewers at the right moment, without sensitive data ever leaving the environment where it is governed.
The temptation when deploying agentic AI in life sciences is to build a wrapper around your Snowflake environment, an external orchestration layer that calls out to your data, runs a workflow, and calls back with a result. In most industries, that tradeoff is manageable. In GxP environments, it is not. Every data movement is a risk surface. Every external call is an audit question. Every boundary crossed is a validation concern.
The architecture behind ALTi AIOS™ on Snowflake starts from a different premise: intelligence should run where the data lives.
By deploying through Snowflake Cortex AI, Snowpark, and Horizon, ALTi AIOS™ agents operate inside the perimeter you already trust and have already validated. Cortex AI provides model inference natively within Snowflake. Snowpark gives agents the ability to execute complex computation directly against your data without extraction. Horizon extends governance and access control to cover every agent action, which agent touched which data, under what policy, and with what outcome, all without sensitive data leaving your secure environment.
This is not integration depth for its own sake. It is a governing principle: in life sciences, compliance cannot be bolted on after the fact. It has to be built into the substrate. Running ALTi AIOS™ inside Snowflake means the security posture, data lineage, and compliance controls are the same ones your organization already maintains, validates, and audits.
The life sciences workflows with the most operational drag are also the most amenable to agentic execution, because they are structured, rule-bound, and require coordinated action across multiple data sources.
Take COA mapping and batch release. The decision to release a batch is not a simple lookup. It requires pulling specifications from one source, actual results from another, comparing them against acceptance criteria, flagging deviations against the historical deviation log, and checking whether outstanding CAPAs affect the batch, then producing a release recommendation with a complete evidence trail. A human reviewer acts on that recommendation with full visibility into how the agent reached it. What used to require hours of manual cross-referencing becomes a governed, auditable workflow executed in minutes, with the human in the loop for the decision that matters.
CAPA reviews follow the same pattern. An agent traverses the quality event history, correlates deviation patterns, identifies systemic root causes spanning multiple batches or sites, drafts the CAPA recommendation, and routes it for approval, all within the Snowflake environment, all with a complete audit trail satisfying 21 CFR Part 11 and GMP requirements.
Every action carries three things: the data it acted on, the logic it applied, and a mandatory human approval gate before any regulated decision is finalized. The audit trail is not a feature added at the end, it is the first thing we build.
The shift we are bringing to Snowflake World Tour Chicago is not incremental. It is the next chapter for life sciences organizations that have already built their foundation on Snowflake.
A data lake is a place where evidence accumulates. An active system of intelligence is a place where that evidence drives governed action. The same Snowflake environment, the same data assets, the same governance framework, but now specialized agents are running GxP workflows on top of it, not just queries.
The enterprises that move fastest in the next phase of life sciences AI will not be the ones with the best data. Most already have good data. They will be the ones that stop treating their data estate as a source of insight and start treating it as a substrate for action, one where agents coordinate, governance enforces at runtime, exceptions route to human reviewers, and every decision leaves an audit trail by default.
ALTi AIOS™ on Snowflake is built to be that layer. The data is already there. The governance is already in place. What remains is activating it.
A different approach to security modernization: prevent what you can, prioritize what matters, automate what makes sense, and prove continuously that your controls are working. Ask any CISO how the vulnerability program is going, and you’ll get the same answer: ‘We’re making progress.’ Tickets are closing. Patches are shipping. The dashboard is green. And still, […]
Introduction Merchant acquiring crossed a threshold in January 2026, when Global Payments completed its $24.25 billion acquisition of Worldpay. The combined company now serves more than 6 million merchant locations, processing $3.7 trillion in payment volume and approximately 94 billion transactions annually across more than 175 countries. That is scale on paper. Scale in production […]
A relationship manager at a regional bank has a client meeting at 10 a.m. At 9:15, she opens Financial Services Cloud (FSC) for the customer’s household relationships, logs into the core banking system for recent transactions, and finishes in the advisor portal, checking open referrals and service cases. She arrives just in time for the […]
